State Pharmacopoeia presented at the 9th International Conference "Abu Ali ibn Sino and Innovations in Modern Pharmaceutics" with a dedicated exhibition stand

On 22 May, the State Pharmacopoeia development department took part in the 9th international conference at the Tashkent Pharmaceutical Institute with a dedicated exhibition stand.
On May 22, 2026, employees of the Department of State Pharmacopoeia Development took an active part in the IX International Scientific and Practical Conference "Abu Ali Ibn Sina and Innovations in Modern Pharmaceuticals" held at the Tashkent Pharmaceutical Institute.
Within the framework of the conference, information materials and visual exhibitions were presented, highlighting the state pharmacopoeia of the Republic of Uzbekistan, including its essence, structure, stages of development and its significance in the development of the country’s pharmaceutical sector.
The exhibition booth aroused great interest among conference participants, local and foreign experts, professors, researchers and students. During the event, the staff of the department gave comprehensive explanations to the participants on the issues of State Pharmacopoeia, quality assurance of medicines, development of pharmacopoeia articles and harmonization with international standards, and scientifically based answers to questions of interest were provided. Also, interviews were organized by representatives of the visiting media and central television to cover the conference, describing the activities of the department, exhibition materials related to the State Pharmacopoeia and the work being carried out.

Abu Ali Ibn Sina and Innovations in Modern Pharmaceuticals" Specialists of the department who participated in the IX International Scientific and Practical Conference
Participation in this conference served to acquaint the general public with the activities of the Department for the Development of State Pharmacopoeia, to promote the importance of the State Pharmacopoeia of the Republic of Uzbekistan, to strengthen scientific and practical cooperation in the field and to further increase the prestige of national pharmacopoeia.